503B Outsourcing Facility

FDA Proposes Exclusion of GLP-1s from the 503B Bulks List: Implications for Outsourcing Facilities

The U.S. Food and Drug Administration (FDA) continues to refine the regulatory framework governing compounded medications, introducing significant implications...

Optimizing Metabolic Protocols: The Synergistic Role of Levocarnitine, L-Arginine, and Active B12

Medical weight management continues to evolve as practitioners seek safe, effective adjunctive therapies to support patients beyond standard diet and exercise r...